---
category: news
title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"
excerpt: "“As each patient’s cancer is unique, we have developed a therapy that turns their ... from its world-leading expertise in artificial intelligence and its unique algorithm that is used to ..."
publishedDateTime: 2020-01-07T00:12:00Z
sourceUrl: https://www.businesswire.com/news/home/20200106006021/en/Transgene-NEC-Start-Clinical-Trials-TG4050-AI-Powered
type: article
quality: 14
heat: 14
published: false

provider:
  name: Business Wire
  domain: businesswire.com

topics:
  - AI
  - AI in Healthcare

images:
  - url: https://mms.businesswire.com/media/20200106006021/en/765262/23/NEC.jpg
    width: 1200
    height: 627
    title: "Transgene and NEC Start Two Clinical Trials with TG4050, an AI-Powered Cancer Vaccine for Ovarian and Head & Neck Cancers"

secured: "7qYGiKNZTueXdGWBDYaI3eU/2uydteSWzih6J+wmrnqjZk/HUFkE9GMWVL5AEbNj4EdWVoebHRNU+dXiMu0L9WfoxfTUsSZEPSCJgVmSTQNZlJWBSyv6AL5FyLxvS1seb1DhThN5OxynVvvCBlOc4JWGuypy6FgQxPWPzWuugO2Tsl6FZG5CwKUPoVT2hA11fX/kNTPbh9CZ801QxQ4EdwwRfg849hzMb9yUjq6YknKGc6+ijmLtq7g8+2bDPFt0nYtp2vjN4/7OXT3qjyMD649ISI3GWVX8jryyyEUyZ9tWNyj2zFbibUPwi4Qx8fq2;ukxVmR5TKh36tC59GWFp0w=="
---

